OBIO H2BB is now offering top graduate-level, business-trained students and recent graduates, who will expand your business, marketing and/or finance strategies through market research, investor targeting, or conference preparation.
Biotechnology Focus magazine is conducting a survey to gauge Canada’s innovation culture. In support of Global Biotech Week (Sept 24-30), add your voice to the Innovation Report by taking this quick survey by July 27th.
On June 25th, OBIO organized a workshop with two industry leaders and provided a VC perspective on how they valuate start-up companies and on how this is translated into a deal structure, featuring presentations by Richard Meadows (General Partner, BioInnovation Capital Fund & OBIO Board Director) and Andy Haigh (COO, Adapsyn Bioscience).
KisoJi, SoundBite and Zucara, three of Accel-Rx’s portfolio companies, together raised a total of $40 million CDN in follow-on funding to advance the development and commercialization of their technologies.